RNA Interference – Application to Drug Discovery and Challenges to Pharmaceutical Development
Wiley-Blackwell (Hersteller)
978-0-470-92373-3 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
PAUL H. JOHNSON, PhD , is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.
CONTRIBUTORS. PREFACE. FOREWORD. I. Biology of RNA Interference. 1 RNA Interference: What is it? (James A. Birchler). 2 Nucleic Acids as Regulatory Molecules (Faqing Huang, C. J. Yu, and Yanlin Guo). 3 Use of siRNA Oligonucleotides to Study Gene Function (Kristin A. Wiederholt and Adam N. Harris). 4 Genome Scanning by RNA Interference (Roderick L. Beijersbergen and Oliver C. Steinbach). II Development of siRNA for Therapeutic Applications. 5 Discovery of New siRNA Delivery Agents (Paul H. Johnson, Diane Frank, Kunyuan Cui, Roger Adami, Harry Wang, Michael Houston, and Steven C. Quay). 6 siRNA Delivery Vehicles (Aliasger K. Salem and Mark A. Behlke). 7 Interferon, Cytokine Induction and Other Potential In Vivo Toxicities (Adam Judge, Marjorie Robbins, and Ian MacLachlan). 8 Application of RNA Interference to Viral Diseases (Ralph A. Tripp and Stephen Mark Tompkins). Index.
| Erscheint lt. Verlag | 30.11.2010 |
|---|---|
| Vorwort | John J. Rossi |
| Verlagsort | Hoboken |
| Sprache | englisch |
| Maße | 150 x 250 mm |
| Gewicht | 666 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
| Naturwissenschaften ► Chemie | |
| ISBN-10 | 0-470-92373-3 / 0470923733 |
| ISBN-13 | 978-0-470-92373-3 / 9780470923733 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |